Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same

• US 10,005,038 B2
• Filed: 09/02/2015
• Issued: 06/26/2018
• Est. Priority Date: 09/02/2014
• Status: Active Grant

• Current Assignee: Lockheed Martin Corporation (Martin Marietta Corporation)
• Original Assignee: Lockheed Martin Corporation (Martin Marietta Corporation)
• Inventors: Stetson, Jr., John B., Simon, Sarah, Swett, Jacob L.
• Primary Examiner(s): BASS, DIRK R
• Application Number:
  US14/843,944
• Publication Number:
  US 20160058932A1
• Time in Patent Office: 1,028 Days
• Field of Search: 210435, 210646
• CPC Class Codes: A61M 1/1631 having non-tubular membranes, e.g. sheets
• CPC Class Codes: B01D 2319/025 Permeate series
• CPC Class Codes: B01D 2319/06 Use of membranes of different materials or properties within one module
• CPC Class Codes: B01D 63/08 Flat membrane modules
• CPC Class Codes: B01D 71/0211 Graphene or derivates thereof

Abstract

Perforated graphene and other perforated two-dimensional materials can be used in hemodialysis membranes and blood filtration membranes for selective removal of components from blood in vivo and ex vivo. The membranes are useful in hemodialysis and hemofiltration techniques to provide improved patient care. Hemodialysis systems can include a hemodialysis membrane formed from perforated graphene or another perforated two-dimensional material disposed upon a porous support structure. Hemofiltration systems can include one or more and preferably two or more blood filtration membrane formed from perforated graphene or another perforated two-dimensional material disposed upon a porous support structure. Methods for performing hemodialysis can involve exposing blood from a patient to a hemodialysis membrane formed from a perforated two-dimensional material. Ex vivo dialysis techniques can be performed similarly. Methods for filtration of blood can involve passing blood through one or more filter membranes or through a plurality of sequential filter membranes.

Claims

1. A medical device comprising:

an enclosure comprising a blood filtration membrane, wherein the blood filtration membrane comprises a perforated two-dimensional material comprising perforated graphene, the perforated two-dimensional material being disposed upon a porous support structure, and

renal tubule cells disposed within the enclosure;

wherein;

the perforated graphene is configured to retain the renal tubule cells; and

the perforated graphene is configured to allow selective entry and/or exit of at least one component contained in blood into and/or out of the enclosure.

2. The medical device of claim 1, wherein the perforated two-dimensional material is graphene-based material.

3. The medical device of claim 2, wherein the graphene-based material is single-layer graphene.

4. The medical device of claim 1, wherein the perforated two-dimensional material is graphene oxide.

9. The medical device of claim 1, wherein:

the perforated graphene is configured to deny selective entry of at least one component contained in blood into the enclosure; and

the at least one component denied entry comprises one or more proteins.

13. The medical device of claim 1, wherein the porous structure comprises a biocompatible polymer selected from the group of poly(methyl methacrylate) (PMMA), polyesters, polyamides, polyimides, polyethylene, polypropylene, polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), polycarbonate, polyetherether-ketone polymers, polyaryletheretherketone, polyvinyl chloride (PVC), and mixtures, copolymers or block copolymers thereof.

14. The medical device of claim 1, wherein the at least one component contained in blood comprises a waste product.

15. The medical device of claim 14, wherein the waste product comprises urea.

16. The medical device of claim 9, wherein the one or more proteins comprise albumin.

17. The medical device of claim 1, wherein the medical device is a bioartificial kidney.

5. A method comprising:

exposing blood to a blood filtration device, the blood filtration device comprising;

an enclosure comprising a blood filtration membrane, wherein the blood filtration membrane comprises a perforated two-dimensional material comprising perforated graphene, the perforated two-dimensional material being disposed upon a porous support structure, and

renal tubule cells disposed within the enclosure;

wherein;

the perforated graphene is configured to retain the renal tubule cells; and

the perforated graphene is configured to allow selective entry and/or exit of at least one component contained in blood into and/or out of the enclosure.

6. The method of claim 5, wherein the perforated two-dimensional material is graphene-based material.

7. The method of claim 6, wherein the graphene-based material is single-layer graphene.

8. The method of claim 5, wherein the perforated two-dimensional material is graphene oxide.

10. The method of claim 5, further comprising implanting the blood filtration membrane into a subject in need thereof.

11. The method of claim 10, wherein the subject is a diabetic subject.

12. The method of claim 10, wherein the method is a method of treating diabetes.

18. The method of claim 5, wherein the at least one component contained in blood comprises a waste product and the waste product comprises urea.

19. The method of claim 5, wherein when the blood filtration membrane is contacted with blood at least one component contained in the blood is denied selective entry into the device;

and

the at least one component denied entry comprises one or more proteins.

20. A blood filtration device comprising:

an enclosure comprising a blood filtration membrane, wherein the blood filtration membrane comprises at least one layer of a perforated two-dimensional graphene, the perforated two-dimensional material being disposed upon a porous support structure, and

renal tubule cells disposed within the enclosure;

wherein;

the perforated graphene comprises apertures about 30 nm or less in size.